International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

Article type

Original Article


Article page

314-319


Authors Details

Hülya Çiçek*, Abdalrhman Kuba, Mete Gürol Uğur, Elif Bacak Güllü, Neslihan Tepe


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 445

PDF Downloaded: 245


Assessment of serum markers in preeclampsia: A prospective study


Original Article

Author Details : Hülya Çiçek*, Abdalrhman Kuba, Mete Gürol Uğur, Elif Bacak Güllü, Neslihan Tepe

Volume : 10, Issue : 4, Year : 2023

Article Page : 314-319

https://doi.org/10.18231/j.ijcbr.2023.056



Suggest article by email

Get Permission

Abstract

Preeclampsia is a disease characterized by hypertension, proteinuria, and edema that occurs after the 20th gestational week. It is among the most important reasons for maternal/perinatal morbidity and mortality. Although many studies have been carried out, the pathophysiology of the disease is not fully known. Many methods have been proposed for evaluating risk factors leading to preeclampsia. In the past, the methods used to predict preeclampsia have usually been focused on non-biochemical markers, but nowadays there is a shift towards biochemical markers. Recently, many biochemical agents have been started to be used in the prediction of preeclampsia. In this study, the evaluation of some serum biomarkers in the follow-up preeclampsia was aimed. Serum nesfatin, ezrin, placental protein 13, hypoxia-inducible factor 1-? subunit (HIF1A), and neuropilin 1 levels were examined with the ELISA method. In the study, 90 samples taken from subjects, including pre-treatment preeclampsia (n =35), post-treatment preeclampsia (n = 35), and healthy control (n = 20) groups were evaluated. The data obtained from the study was analyzed with SPSS 22.0. As a result of the statistical analysis, pre-treatment nesfatin-1, and ezrin levels were found significantly lower than post-treatment and the healthy control group and HIF-1A levels were found significantly higher. As a result of these analyses, pre-treatment and post-treatment PP13 levels were found to be significantly higher than the healthy control group.Considering the results obtained from the study, we can say that nestin, ezrin, HIF1A, PP13, and NRP1 are important biomarkers for predicting preeclampsia.
 

Keywords: Preeclampsia, Hypoxia- inducible factor 1-? subunit, Nesfatin, Ezrin, Placental protein 13, Neuropilin


How to cite : Çiçek H, Kuba A, Uğur M G, Güllü E B, Tepe N, Assessment of serum markers in preeclampsia: A prospective study. Int J Clin Biochem Res 2023;10(4):314-319

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.